RxDoctor Payments Data

Henry Boucher, MD

Orthopaedic Surgery · Baltimore, MDNPI 1013953728

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (52.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Aesculap AG at 51.8% of the total. Reporting peaked in 2019 at $165,744 and has fallen 98.9% since, to $1,856 in 2025. Among orthopaedic surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$315,348in general payments, 2019–2025

Across 184 payments — averaging $1713.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aesculap AG$163K
  • Stryker$105K
  • Globus Medical$39K
  • Depuy Synthes Products, Inc.$8K
  • Zimmer Biomet$545
  • Johnson & Johnson$83
  • plus $133 from 3 others
$66,106in research payments, 2019–2025

Across 24 payments — averaging $2754.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$66K

What the payments were for

  • Royalty or licence$165,00252%
  • Consulting fees$127,58440%
  • Speaking & faculty fees$4,8002%
  • Travel & lodging$15,2165%
  • Food & beverage$2,7461%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$315,348 in reported general payments places this provider in the 95th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$192,338
Medicare patients
249
Services billed
507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →